Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders
Anti-SARS-CoV-2 IgA, 최초 응답자의 무증상 감염 식별
Article
[키워드] added
anti-Nucleocapsid IgG
Anti-spike
anti-Spike IgG
antibody
Asymptomatic
asymptomatic infection
baseline
benefit
correlated
COVID-19
cumulative
cumulative incidence
emergency medical service
Epidemiology
estimates
exposure to
First responder
first responders
Follow-up
General population
group
high risk
IgA
IgG
illness
illnesses
immune response
Immunoglobulin
immunoglobulin A
IMPROVE
incidence
infection with SARS-CoV-2
longitudinal
majority
medical service
police
positive
provided
Responder
retrospective
risk
SARS-CoV-2
SARS-COV-2 infection
serologic surveys
serologic test
serologic tests
seropositive
Serosurvey
Serosurveys
spike IgA
were assessed
with COVID-19
[DOI] 10.1093/infdis/jiab524 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/infdis/jiab524 PMC 바로가기 [Article Type] Article